Rein Therapeutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis (NCT06968845) | Rein Therapeutics | 2026-02-02 |
| A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients (NCT05954988) | Rein Therapeutics | 2023-07-06 |
| A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions (NCT04159831) | Rein Therapeutics | 2020-09-26 |
| Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects (NCT04233814) | Rein Therapeutics | 2020-01-20 |
Track Rein Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.